A Study of LY3025876 in Participants With Diabetes
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess the safety and tolerability of LY3025876 given
alone (Part A) and in combination with liraglutide (Part B) in participants with type 2
diabetes mellitus (T2DM).